Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe

Francesca Malentacchi, Irene Mancini, Ivan Brandslund, Pieter Vermeersch, Matthias Schwab, Janja Marc, Ron H N Van Schaik, Gerard Siest, Elvar Theodorsson, Mario Pazzagli, Chiara Di Resta, Federation of Clinical Chemistry European Federation of Clinical Chemistry, Society of Pharmacogenomics European Society of Pharmacogenomics

Research output: Contribution to journalArticle

Abstract

Developments in "-omics" are creating a paradigm shift in laboratory medicine leading to personalized medicine. This allows the increase in diagnostics and therapeutics focused on individuals rather than populations. In order to investigate whether laboratory medicine is ready to play a key role in the integration of personalized medicine in routine health care and set the state-of-the-art knowledge about personalized medicine and laboratory medicine in Europe, a questionnaire was constructed under the auspices of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and the European Society of Pharmacogenomics and Personalised Therapy (ESPT). The answers of the participating laboratory medicine professionals indicate that they are aware that personalized medicine can represent a new and promising health model, and that laboratory medicine should play a key role in supporting the implementation of personalized medicine in the clinical setting. Participants think that the current organization of laboratory medicine needs additional/relevant implementations such as (i) new technological facilities in -omics; (ii) additional training for the current personnel focused on the new methodologies; (iii) incorporation in the laboratory of new competencies in data interpretation and counseling; and (iv) cooperation and collaboration among professionals of different disciplines to integrate information according to a personalized medicine approach.

Original languageEnglish
Pages (from-to)121-128
Number of pages8
JournalDrug Metabolism and Personalized Therapy
Volume30
Issue number2
DOIs
Publication statusPublished - Jun 1 2015

Fingerprint

Hospital Laboratories
Precision Medicine
Medicine
Clinical Chemistry
Surveys and Questionnaires
Pharmacogenetics
Counseling
Delivery of Health Care
Health
Therapeutics

Keywords

  • "-omics" technologies
  • laboratory medicine
  • personalized medicine

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Malentacchi, F., Mancini, I., Brandslund, I., Vermeersch, P., Schwab, M., Marc, J., ... European Society of Pharmacogenomics, S. O. P. (2015). Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe. Drug Metabolism and Personalized Therapy, 30(2), 121-128. https://doi.org/10.1515/dmdi-2015-0012

Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe. / Malentacchi, Francesca; Mancini, Irene; Brandslund, Ivan; Vermeersch, Pieter; Schwab, Matthias; Marc, Janja; Van Schaik, Ron H N; Siest, Gerard; Theodorsson, Elvar; Pazzagli, Mario; Di Resta, Chiara; European Federation of Clinical Chemistry, Federation of Clinical Chemistry; European Society of Pharmacogenomics, Society of Pharmacogenomics.

In: Drug Metabolism and Personalized Therapy, Vol. 30, No. 2, 01.06.2015, p. 121-128.

Research output: Contribution to journalArticle

Malentacchi, F, Mancini, I, Brandslund, I, Vermeersch, P, Schwab, M, Marc, J, Van Schaik, RHN, Siest, G, Theodorsson, E, Pazzagli, M, Di Resta, C, European Federation of Clinical Chemistry, FOCC & European Society of Pharmacogenomics, SOP 2015, 'Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe', Drug Metabolism and Personalized Therapy, vol. 30, no. 2, pp. 121-128. https://doi.org/10.1515/dmdi-2015-0012
Malentacchi, Francesca ; Mancini, Irene ; Brandslund, Ivan ; Vermeersch, Pieter ; Schwab, Matthias ; Marc, Janja ; Van Schaik, Ron H N ; Siest, Gerard ; Theodorsson, Elvar ; Pazzagli, Mario ; Di Resta, Chiara ; European Federation of Clinical Chemistry, Federation of Clinical Chemistry ; European Society of Pharmacogenomics, Society of Pharmacogenomics. / Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe. In: Drug Metabolism and Personalized Therapy. 2015 ; Vol. 30, No. 2. pp. 121-128.
@article{faa19167e153434ca32e6351f8c1b2c0,
title = "Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe",
abstract = "Developments in {"}-omics{"} are creating a paradigm shift in laboratory medicine leading to personalized medicine. This allows the increase in diagnostics and therapeutics focused on individuals rather than populations. In order to investigate whether laboratory medicine is ready to play a key role in the integration of personalized medicine in routine health care and set the state-of-the-art knowledge about personalized medicine and laboratory medicine in Europe, a questionnaire was constructed under the auspices of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and the European Society of Pharmacogenomics and Personalised Therapy (ESPT). The answers of the participating laboratory medicine professionals indicate that they are aware that personalized medicine can represent a new and promising health model, and that laboratory medicine should play a key role in supporting the implementation of personalized medicine in the clinical setting. Participants think that the current organization of laboratory medicine needs additional/relevant implementations such as (i) new technological facilities in -omics; (ii) additional training for the current personnel focused on the new methodologies; (iii) incorporation in the laboratory of new competencies in data interpretation and counseling; and (iv) cooperation and collaboration among professionals of different disciplines to integrate information according to a personalized medicine approach.",
keywords = "{"}-omics{"} technologies, laboratory medicine, personalized medicine",
author = "Francesca Malentacchi and Irene Mancini and Ivan Brandslund and Pieter Vermeersch and Matthias Schwab and Janja Marc and {Van Schaik}, {Ron H N} and Gerard Siest and Elvar Theodorsson and Mario Pazzagli and {Di Resta}, Chiara and {European Federation of Clinical Chemistry}, {Federation of Clinical Chemistry} and {European Society of Pharmacogenomics}, {Society of Pharmacogenomics}",
year = "2015",
month = "6",
day = "1",
doi = "10.1515/dmdi-2015-0012",
language = "English",
volume = "30",
pages = "121--128",
journal = "Drug Metabolism and Personalized Therapy",
issn = "2363-8907",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "2",

}

TY - JOUR

T1 - Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe

AU - Malentacchi, Francesca

AU - Mancini, Irene

AU - Brandslund, Ivan

AU - Vermeersch, Pieter

AU - Schwab, Matthias

AU - Marc, Janja

AU - Van Schaik, Ron H N

AU - Siest, Gerard

AU - Theodorsson, Elvar

AU - Pazzagli, Mario

AU - Di Resta, Chiara

AU - European Federation of Clinical Chemistry, Federation of Clinical Chemistry

AU - European Society of Pharmacogenomics, Society of Pharmacogenomics

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Developments in "-omics" are creating a paradigm shift in laboratory medicine leading to personalized medicine. This allows the increase in diagnostics and therapeutics focused on individuals rather than populations. In order to investigate whether laboratory medicine is ready to play a key role in the integration of personalized medicine in routine health care and set the state-of-the-art knowledge about personalized medicine and laboratory medicine in Europe, a questionnaire was constructed under the auspices of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and the European Society of Pharmacogenomics and Personalised Therapy (ESPT). The answers of the participating laboratory medicine professionals indicate that they are aware that personalized medicine can represent a new and promising health model, and that laboratory medicine should play a key role in supporting the implementation of personalized medicine in the clinical setting. Participants think that the current organization of laboratory medicine needs additional/relevant implementations such as (i) new technological facilities in -omics; (ii) additional training for the current personnel focused on the new methodologies; (iii) incorporation in the laboratory of new competencies in data interpretation and counseling; and (iv) cooperation and collaboration among professionals of different disciplines to integrate information according to a personalized medicine approach.

AB - Developments in "-omics" are creating a paradigm shift in laboratory medicine leading to personalized medicine. This allows the increase in diagnostics and therapeutics focused on individuals rather than populations. In order to investigate whether laboratory medicine is ready to play a key role in the integration of personalized medicine in routine health care and set the state-of-the-art knowledge about personalized medicine and laboratory medicine in Europe, a questionnaire was constructed under the auspices of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and the European Society of Pharmacogenomics and Personalised Therapy (ESPT). The answers of the participating laboratory medicine professionals indicate that they are aware that personalized medicine can represent a new and promising health model, and that laboratory medicine should play a key role in supporting the implementation of personalized medicine in the clinical setting. Participants think that the current organization of laboratory medicine needs additional/relevant implementations such as (i) new technological facilities in -omics; (ii) additional training for the current personnel focused on the new methodologies; (iii) incorporation in the laboratory of new competencies in data interpretation and counseling; and (iv) cooperation and collaboration among professionals of different disciplines to integrate information according to a personalized medicine approach.

KW - "-omics" technologies

KW - laboratory medicine

KW - personalized medicine

UR - http://www.scopus.com/inward/record.url?scp=84930971839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930971839&partnerID=8YFLogxK

U2 - 10.1515/dmdi-2015-0012

DO - 10.1515/dmdi-2015-0012

M3 - Article

C2 - 26036226

AN - SCOPUS:84930971839

VL - 30

SP - 121

EP - 128

JO - Drug Metabolism and Personalized Therapy

JF - Drug Metabolism and Personalized Therapy

SN - 2363-8907

IS - 2

ER -